Literature DB >> 2673827

Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom.

J A Frost1, H R Smith, G A Willshaw, S M Scotland, R J Gross, B Rowe.   

Abstract

Vero-cytotoxin (VT) producing Escherichia coli serogroup O157 have been isolated from patients with diarrhoea, haemorrhagic colitis (HC) and haemolytic uraemic syndrome (HUS). A phage-typing scheme developed in Canada has been used to type 155 VT+ E. coli O157 serogroup isolated from sporadic infections in the UK since 1983, and 48 strains from HC or HUS outbreaks. Twelve phage types were identified of which three, types 49, 51 and 52, have not been found in North America. All strains carried a 60 x 10(6) plasmid and most VT1+VT2+ strains also had a 5 x 10(6) plasmid coding for colicin D production. The majority of strains producing both VT1 and VT2 belonged to phage type 1, or the related types 4, 8 and 14. Most strains producing only VT2 belonged to types 2 or 49. Four outbreaks were included in the survey. Three had strains of a single phage type while strains from the fourth outbreak were more variable. The distribution of phage types throughout the UK showed no marked geographical variations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673827      PMCID: PMC2249488          DOI: 10.1017/s0950268800030375

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada.

Authors:  W M Johnson; H Lior; G S Bezanson
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

2.  Two distinct toxins active on Vero cells from Escherichia coli O157.

Authors:  S M Scotland; H R Smith; B Rowe
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Escherichia coli K12 strains for use in the identification and characterization of colicins.

Authors:  A P Pugsley
Journal:  J Gen Microbiol       Date:  1985-02

4.  Cloning of genes determining the production of vero cytotoxin by Escherichia coli.

Authors:  G A Willshaw; H R Smith; S M Scotland; B Rowe
Journal:  J Gen Microbiol       Date:  1985-11

5.  Characterization of Escherichia coli serotype O157:H7.

Authors:  S Ratnam; S B March; R Ahmed; G S Bezanson; S Kasatiya
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

8.  Application of agarose gel electrophoresis to the characterization of plasmid DNA in drug-resistant enterobacteria.

Authors:  G A Willshaw; H R Smith; E S Anderson
Journal:  J Gen Microbiol       Date:  1979-09

9.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  12 in total

1.  Genetic diversity among Escherichia coli O157:H7 isolates from Bovines living on farms in England and Wales.

Authors:  Ernesto Liebana; Richard P Smith; Elisabeth Lindsay; Ian McLaren; Claire Cassar; Felicity A Clifton-Hadley; Giles A Paiba
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Phage typing of Vero cytotoxin-producing Escherichia coli O 157 isolated in the United Kingdom: 1989-91.

Authors:  J A Frost; T Cheasty; A Thomas; B Rowe
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

3.  Extended phage-typing scheme for Escherichia coli O157:H7.

Authors:  R Khakhria; D Duck; H Lior
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

4.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Structure and function of plasmid pColD157 of enterohemorrhagic Escherichia coli O157 and its distribution among strains from patients with diarrhea and hemolytic-uremic syndrome.

Authors:  C Hofinger; H Karch; H Schmidt
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157.

Authors:  A Thomas; H R Smith; B Rowe
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Combined use of two genetic fingerprinting methods, pulsed-field gel electrophoresis and ribotyping, for characterization of Escherichia coli O157 isolates from food animals, retail meats, and cases of human disease.

Authors:  S M Avery; E Liebana; C-A Reid; M J Woodward; S Buncic
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Molecular epidemiology of Escherichia coli O157:H7 by restriction fragment length polymorphism using Shiga-like toxin genes.

Authors:  M Samadpour
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

10.  Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7.

Authors:  S E Murinda; R F Roberts; R A Wilson
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.